Xtandi 80 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FCMQX
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,820
Award facts
- Contract value 100% obligated
- $16,820.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award, valued at $16,820.12, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4568103990 - XTANDI 80 MG TABLET 60S, a prescription medication, with a performance period ending on May 2, 2025.
DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items supporting the medical supply needs of military health facilities worldwide. The contract covers an extensive portfolio of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories.
The contract award is not designated as a set-aside, and there are no major subcontractors mentioned. The DLA is the funding agency for this procurement, which aligns with the agency's mission of providing medical supplies and medications to the Department of Defense healthcare system.
Quick answers
Who was awarded contract SPE2DB25FCMQX?
SPE2DB25FCMQX was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on May 1, 2025.
How much is contract SPE2DB25FCMQX worth?
The government has obligated $16,820 on SPE2DB25FCMQX.
Is contract SPE2DB25FCMQX an order under another contract?
Yes. SPE2DB25FCMQX is a delivery order under SPE2DB24D9144, an indefinite delivery contract.
Was contract SPE2DB25FCMQX competed?
The extent of competition for SPE2DB25FCMQX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award